The Latest Prospects for Cancer Treatment

Jan 14, 2019

Credit J. Junker

Cancers are a leading cause of death worldwide. Nearly 40 percent of us are diagnosed with cancer at some point in our lives. And cancer care cost close to $150 billion in 2017. Of course, we also spend billions on cancer research to develop new ways to better detect and treat cancers. 

In 2018, the FDA approved 18 new cancer drugs and approved the expanded use of ten more. So what might we expect in 2019? Elaine Mardis is professor of pediatrics and Co-Executive Director of The Institute for Genomic Medicine at Nationwide Children's Hospital in Columbus, Ohio. She’s also President-Elect of the American Association for Cancer Research. She spoke with Living Lab Radio.